TRUE NORTH THERAPEUTICS
True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases of high unmet clinical need. The company’s lead monoclonal antibody, TNT009, targets the Classical Complement pathway, enabling selective inhibition of downstream phagocytosis, inflammation, and cell lysis. True North is currently focused on Complement-mediated rare diseases in the hematologic, kidney transplant, dermatology, and neurological space. True North was formed in 2013 as a spin-out of iPierian.
TRUE NORTH THERAPEUTICS
Social Links:
Industry:
Biotechnology Clinical Trials Health Care
Founded:
2013-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.truenorthrx.com
Total Employee:
11+
Status:
Closed
Contact:
(650) 872-4700
Email Addresses:
[email protected]
Total Funding:
142 M USD
Technology used in webpage:
SPF Google Maps Microsoft Azure DNS Proofpoint Symantec.cloud
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Mission BioCapital
Mission BioCapital investment in Venture Round - True North Therapeutics
Franklin Templeton Investments
Franklin Templeton Investments investment in Series D - True North Therapeutics
Redmile Group
Redmile Group investment in Series D - True North Therapeutics
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series D - True North Therapeutics
SR One
SR One investment in Series D - True North Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series D - True North Therapeutics
Kleiner Perkins
Kleiner Perkins investment in Series C - True North Therapeutics
MPM Capital
MPM Capital investment in Series C - True North Therapeutics
Baxalta Ventures
Baxalta Ventures investment in Series C - True North Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series C - True North Therapeutics
Official Site Inspections
http://www.truenorthrx.com
- Host name: 12.203.208.30
- IP address: 12.203.208.30
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
